藥用甘油市場規模、佔有率及成長分析（按類型、原料、應用及地區分類）－2026-2033年產業預測

2024 年全球藥用甘油市場規模為 4,108 萬美元，預計從 2025 年的 4,383 萬美元成長到 2033 年的 7,364 萬美元，預計在預測期（2026-2033 年）內將以 6.7% 的複合年成長率成長。

全球藥用甘油市場正蓬勃發展，這主要得益於其安全性和多功能性，使其廣泛應用於膠囊、糖漿和外用製劑等藥物配方中。尤其是在新興市場，對止咳糖漿、創傷護理軟膏和甘油膠囊的需求不斷成長，推動了甘油的消費。製藥業的成長，特別是亞太和拉丁美洲地區的成長，以及能夠生產高純度產品的製造技術的進步，都進一步促進了這一趨勢。向植物來源甘油的轉變符合對永續生物基原料的需求。然而，原料供應波動、與藥用級認證相關的生產成本以及供應鏈中斷等挑戰可能會影響定價策略和市場動態，尤其對中小型製造商而言。

推動全球藥用甘油市場發展的因素

全球藥用甘油市場正經歷顯著成長，這主要得益於其在各種藥物製劑（包括糖漿、膠囊、軟膏和給藥系統）中的廣泛應用。這項需求激增主要由製藥業的擴張所驅動，尤其是在醫療保健技術快速發展的新興國家。此外，生物製藥生產的日益重視以及向創新複雜藥物製劑的轉變，預計將進一步推動對高品質藥用甘油的需求。甘油的安全性、穩定性和保濕特性使其成為不斷發展的製藥行業中不可或缺的成分。

限制全球藥用甘油市場的因素

全球藥用甘油市場面臨許多挑戰，主要原因是其高度依賴棕櫚油和大豆油等原料，極易受到市場波動的影響。氣候變遷、貿易限制以及生質柴油產業的波動等因素都會對甘油的供應和價格產生重大影響。這些波動會擾亂供應鏈，使中小生產商，尤其是那些專注於藥用輔料的生產商，難以維持生產計劃並確保盈利。這可能導致市場不穩定，進而影響整個產業的成長和競爭力。

全球藥用甘油市場趨勢

全球藥用甘油市場正經歷著向植物來源甘油的顯著轉變，這主要受消費者對永續性和純素替代品的需求日益成長的推動。這一市場趨勢的特點是，消費者越來越傾向於選擇符合道德規範、潔淨標示的產品，這些產品需要滿足更高的透明度和環境責任標準。隨著製藥公司積極響應消費者壓力和監管要求，從傳統的動物性成分向植物來源甘油的過渡正在加速，尤其是在歐洲和北美等地區。這項變化不僅反映了消費者偏好的轉變，也標誌著製藥業對永續實踐的更廣泛承諾。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 二手資料和一手資料方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭格局概述

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境
• 技術評估

全球藥用甘油市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 純度99.7%
• 純度99.7%或更高

全球藥用甘油市場規模（按來源和複合年成長率分類）（2026-2033 年）

• 動物源性
• 植物來源

全球藥用甘油市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 口服
• 外用

全球藥用甘油市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• IOI Oleo GmbH（Germany）
• Archer Daniels Midland Company（ADM）（United States）
• KLK Oleo（Malaysia）
• Oleon NV（Belgium）
• Dow, Inc.（United States）
• Cargill, Incorporated（United States）
• Emery Oleochemicals（Malaysia）
• P&G Chemicals（United States）
• Wilmar International Limited（Singapore）
• The Chemical Company（TCC）（United States）
• Godrej Industries Limited（India）
• Twin Rivers Technologies, Inc.（United States）
• VVF LLC（India）
• Avril Group（France）
• GLACONCHEMIE GmbH（Germany）
• Croda International Plc（United Kingdom）
• Rajaram Solvents Pvt. Ltd.（India）
• 3F Chimica SpA（Italy）
• Solvay SA（Belgium）
• Peter Greven GmbH & Co. KG（Germany）

結論與建議

Global Pharmaceutical Glycerine Market size was valued at USD 41.08 Million in 2024 and is poised to grow from USD 43.83 Million in 2025 to USD 73.64 Million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pharmaceutical glycerine market is on an upward trajectory, driven by its applications in drug formulations, including capsules, syrups, and topical products, owing to its safety and versatility. Increasing demand for cough syrups, wound care ointments, and glycerine-based capsules, particularly in emerging markets, is boosting glycerine consumption. Growth in the pharmaceutical sector, especially in Asia-Pacific and Latin America, coupled with advancements in manufacturing yielding higher purity products, accelerates this trend. The shift towards plant-derived glycerine aligns with the demand for sustainable, bio-based raw materials. However, challenges such as raw material supply fluctuations, production costs associated with pharmaceutical-grade certification, and disruptions in supply chains can impact pricing strategies and market dynamics, particularly for smaller manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerine Market Segments Analysis

Global Pharmaceutical Glycerine Market is segmented by Type, Source, Application and region. Based on Type, the market is segmented into 99.7% Purity and Above 99.7% Purity. Based on Source, the market is segmented into Animal and Plant. Based on Application, the market is segmented into Oral Use and External use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is experiencing significant growth driven by its diverse applications in various drug formulations, including syrups, capsules, ointments, and drug delivery systems. This surge in demand is primarily attributed to the expanding pharmaceutical sector, particularly in emerging economies, where healthcare advancements are on the rise. Furthermore, the growing focus on biopharmaceutical production and the shift towards innovative and complex drug formulations are expected to further boost the need for premium pharmaceutical glycerine. Its attributes, such as safety, stability, and moisture retention, make glycerine an essential ingredient in this evolving landscape of pharmaceuticals.

Restraints in the Global Pharmaceutical Glycerine Market

The Global Pharmaceutical Glycerine market faces notable challenges due to its dependence on raw materials such as palm and soybean oils, which can experience market volatility. Factors such as climate change, trade limitations, and variations in the biodiesel sector can significantly impact the availability and pricing of glycerine. These fluctuations may lead to supply chain disruptions, making it difficult for manufacturers to maintain production schedules and profitability, particularly for smaller companies specializing in pharmaceutical excipients. Consequently, the market's stability may be jeopardized, affecting overall growth and competitiveness within the industry.

Market Trends of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is experiencing a notable shift towards the adoption of plant-based glycerine, driven by increasing consumer demand for sustainability and vegan-friendly alternatives. This market trend is characterized by a growing preference for ethically sourced, clean-label products that adhere to higher standards of transparency and environmental responsibility. As pharmaceutical companies respond to consumer pressures and regulatory requirements, the transition from traditional animal-derived sources to plant-derived glycerine is gaining momentum, particularly in regions like Europe and North America. This shift not only reflects changing consumer preferences but also signals a broader commitment to sustainable practices within the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Pharmaceutical Glycerine Market Size by Type & CAGR (2026-2033)

• Market Overview
• 99.7% Purity
• Above 99.7% Purity

Global Pharmaceutical Glycerine Market Size by Source & CAGR (2026-2033)

• Market Overview
• Animal
• Plant

Global Pharmaceutical Glycerine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oral Use
• External use

Global Pharmaceutical Glycerine Market Size & CAGR (2026-2033)

• North America (Type, Source, Application)
  • US
  • Canada
• Europe (Type, Source, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Source, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Source, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Source, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IOI Oleo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (ADM) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLK Oleo (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oleon NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emery Oleochemicals (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P&G Chemicals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilmar International Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Chemical Company (TCC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Godrej Industries Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twin Rivers Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVF LLC (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avril Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GLACONCHEMIE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rajaram Solvents Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3F Chimica SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solvay SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peter Greven GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations